tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
Holding ELVN?
Track your performance easily

Enliven Therapeutics (ELVN) Technical Analysis

287 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Enliven Therapeutics’s (ELVN) Moving Averages Convergence Divergence (MACD) indicator is -0.83, suggesting Enliven Therapeutics is a Buy.
Enliven Therapeutics’s (ELVN) 20-Day exponential moving average is 23.99, while Enliven Therapeutics’s (ELVN) share price is $22.47, making it a Sell.
Enliven Therapeutics’s (ELVN) 50-Day exponential moving average is 24.91, while Enliven Therapeutics’s (ELVN) share price is $22.47, making it a Sell.

Enliven Therapeutics (ELVN) Pivot Points

Dec 22, 2024, 01:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.89
21.44
22.16
22.71
23.43
23.98
24.70
Fibonacci
21.44
21.93
22.23
22.71
23.20
23.50
23.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enliven Therapeutics (ELVN) Moving Averages

Dec 22, 2024, 01:51 PM
Period
Simple
Exponential
MA5
23.16Sell
22.97Sell
MA10
23.42Sell
23.35Sell
MA20
23.91Sell
23.99Sell
MA50
26.15Sell
24.91Sell
MA100
24.78Sell
24.53Sell
MA200
22.83Sell
22.36Buy
Enliven Therapeutics’s (ELVN) 10-Day exponential moving average is 23.35, while Enliven Therapeutics’s (ELVN) share price is $22.47, making it a Sell.
Enliven Therapeutics’s (ELVN) 100-Day exponential moving average is 24.53, while Enliven Therapeutics’s (ELVN) share price is $22.47, making it a Sell.
Enliven Therapeutics’s (ELVN) stock price is $22.47 and Enliven Therapeutics’s (ELVN) 50-day simple moving average is 26.15, creating a Sell signal.
Enliven Therapeutics’s (ELVN) stock price is $22.47 and Enliven Therapeutics’s (ELVN) 100-day simple moving average is 24.78, creating a Sell signal.
Enliven Therapeutics’s (ELVN) stock price is $22.47 and Enliven Therapeutics’s (ELVN) 200-day simple moving average is 22.83, creating a Sell signal.

Enliven Therapeutics (ELVN) Technical Indicators

Dec 22, 2024, 01:51 PM
Name
Value
Implied Action
RSI (14)
39.53
Neutral
STOCH (9,6)
25.17
Neutral
STOCHRSI (14)
21.62
Neutral
MACD (12,26)
-0.83
Buy
ADX (14)
25.05
Neutral
Williams %R
-81.73
Buy
CCI (14)
-143.31
Buy
ATR (14)
1.49
-
Ultimate Oscillator
51.89
Neutral
ROC
-8.02
Sell
Enliven Therapeutics’s (ELVN) Relative Strength Index (RSI) is 39.53, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Trend Strength Indicator (ADX) is 25.05, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Commodity Channel Index (CCI) is -143.31, creating a Buy signal.
Enliven Therapeutics’s (ELVN) Price Rate of Change (ROC) is -8.02, creating a Sell signal.

FAQ

Is ELVN a Buy, Hold, or Sell?
Based on ELVN’s technical indicators, ELVN is a Sell.
    What is ELVN’s RSI (14)?
    ELVN’s RSI (14) is 39.53, which suggests ELVN is a Neutral.
      What is ELVN’s MACD?
      ELVN’s MACD is -0.83, which suggests ELVN is a Buy.
        What is ELVN’s 5-day moving average?
        ELVN’s 5-day moving average is 23.16, which suggests ELVN is a Sell.
          What is ELVN’s 20-day moving average?
          ELVN 20-day moving average is 23.91, which suggests ELVN is a Sell.
            What is ELVN’s 50-day moving average?
            ELVN’s 50-day moving average is 26.15, which suggests ELVN is a Sell.
              What is ELVN’s 200-day moving average?
              ELVN’s 200-day moving average is 22.83, which suggests ELVN is a Sell.
                What is ELVN’s Williams % R (14)?
                ELVN’s Williams % R (14) is -81.73, which suggests ELVN is a Buy.
                  What is ELVN’s CCI (14)?
                  ELVN’s CCI (14) is -143.31, which suggests ELVN is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis